Quantum-Si (QSI) Projected to Post Quarterly Earnings on Tuesday

Key Points

• Quantum-Si (NASDAQ: QSI) is set to release its Q2 2025 earnings report on August 5th, with analyst expectations of a loss of ($0.16) per share and revenue of $1.28 million.
• In the previous quarter, Quantum-Si reported earnings of ($0.11) per share, surpassing estimates, while revenue of $0.84 million fell short of expectations.
• Shares of Quantum-Si opened at $1.78, with a market capitalization of $325.71 million, and 39.90% of the stock owned by institutional investors and hedge funds.

Quantum-Si (NASDAQ:QSI - Get Free Report) is expected to release its Q2 2025 earnings data after the market closes on Tuesday, August 5th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $1.28 million for the quarter.

Quantum-Si (NASDAQ:QSI - Get Free Report) last issued its earnings results on Thursday, May 15th. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.06. Quantum-Si had a negative return on equity of 41.44% and a negative net margin of 2,925.41%. The company had revenue of $0.84 million during the quarter, compared to the consensus estimate of $0.96 million. On average, analysts expect Quantum-Si to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Quantum-Si Trading Down 1.4%

NASDAQ QSI traded down $0.02 on Friday, hitting $1.46. 4,410,124 shares of the stock traded hands, compared to its average volume of 7,412,919. The stock has a 50-day moving average of $1.79 and a 200 day moving average of $1.63. The company has a market capitalization of $267.91 million, a P/E ratio of -2.15 and a beta of 2.87. Quantum-Si has a twelve month low of $0.61 and a twelve month high of $5.77.

Insider Activity

In other news, insider John S. Vieceli sold 21,923 shares of the business's stock in a transaction that occurred on Monday, June 23rd. The shares were sold at an average price of $1.61, for a total transaction of $35,296.03. Following the completion of the transaction, the insider directly owned 842,586 shares of the company's stock, valued at $1,356,563.46. The trade was a 2.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jeffrey Alan Hawkins sold 23,705 shares of the firm's stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $1.61, for a total transaction of $38,165.05. Following the transaction, the chief executive officer directly owned 2,623,011 shares of the company's stock, valued at $4,223,047.71. The trade was a 0.90% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 54,252 shares of company stock worth $87,346 in the last three months. 30.04% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Quantum-Si

A number of large investors have recently added to or reduced their stakes in the stock. Millennium Management LLC purchased a new stake in shares of Quantum-Si in the first quarter valued at about $4,721,000. Invesco Ltd. raised its holdings in Quantum-Si by 177.7% during the first quarter. Invesco Ltd. now owns 103,657 shares of the company's stock worth $124,000 after purchasing an additional 66,336 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Quantum-Si by 23.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 70,552 shares of the company's stock worth $85,000 after purchasing an additional 13,546 shares in the last quarter. 39.90% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

QSI has been the topic of a number of recent analyst reports. Alliance Global Partners reiterated a "buy" rating on shares of Quantum-Si in a research note on Friday, May 16th. HC Wainwright restated a "buy" rating and set a $5.50 price objective on shares of Quantum-Si in a research note on Monday, May 19th.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.